These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 9753304)
1. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor. Elias KA; Cronin MJ; Stewart TA; Carlsen RC Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304 [TBL] [Abstract][Full Text] [Related]
2. Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats. Kroin JS; Buvanendran A; Williams DK; Wagenaar B; Moric M; Tuman KJ; Kerns JM Reg Anesth Pain Med; 2010; 35(4):343-50. PubMed ID: 20607875 [TBL] [Abstract][Full Text] [Related]
3. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. Moore SA; Peterson RG; Felten DL; O'Connor BL J Neurol Sci; 1980 Oct; 48(1):133-52. PubMed ID: 6448276 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Samii A; Unger J; Lange W Neurosci Lett; 1999 Mar; 262(3):159-62. PubMed ID: 10218880 [TBL] [Abstract][Full Text] [Related]
5. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Tomlinson DR; Fernyhough P; Diemel LT Diabetes; 1997 Sep; 46 Suppl 2():S43-9. PubMed ID: 9285498 [TBL] [Abstract][Full Text] [Related]
6. Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats. Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S Exp Neurol; 1992 Feb; 115(2):292-6. PubMed ID: 1735473 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats. Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S J Neurol Sci; 1994 Mar; 122(1):28-32. PubMed ID: 8195800 [TBL] [Abstract][Full Text] [Related]
8. Protection of insulin‑like growth factor 1 on experimental peripheral neuropathy in diabetic mice. Wang H; Zhang H; Cao F; Lu J; Tang J; Li H; Zhang Y; Feng B; Tang Z Mol Med Rep; 2018 Nov; 18(5):4577-4586. PubMed ID: 30221656 [TBL] [Abstract][Full Text] [Related]
9. Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice. Wang L; Chopp M; Szalad A; Lu X; Jia L; Lu M; Zhang RL; Zhang ZG PLoS One; 2016; 11(7):e0159665. PubMed ID: 27438594 [TBL] [Abstract][Full Text] [Related]
10. Near nerve local insulin prevents conduction slowing in experimental diabetes. Singhal A; Cheng C; Sun H; Zochodne DW Brain Res; 1997 Jul; 763(2):209-14. PubMed ID: 9296561 [TBL] [Abstract][Full Text] [Related]
11. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Kellogg AP; Wiggin TD; Larkin DD; Hayes JM; Stevens MJ; Pop-Busui R Diabetes; 2007 Dec; 56(12):2997-3005. PubMed ID: 17720896 [TBL] [Abstract][Full Text] [Related]
14. Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy. Ohgaki K; Nakano K; Shigeta H; Kitagawa Y; Nakamura N; Iwamoto K; Makino M; Takanashi Y; Kajiyama S; Kondo M Diabetes Care; 1998 Apr; 21(4):615-8. PubMed ID: 9571352 [TBL] [Abstract][Full Text] [Related]
15. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats. Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348 [TBL] [Abstract][Full Text] [Related]
17. [Effect of nerve growth factor on chronic peripheral neuropathy in rats induced by 1-bromopropane]. Wu JY; Zhang JB; Chen WJ; Sun DY Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Jul; 35(7):497-500. PubMed ID: 29081097 [No Abstract] [Full Text] [Related]
18. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Yagihashi S; Wada R; Kamijo M; Nagai K Lab Invest; 1993 Mar; 68(3):296-307. PubMed ID: 8383778 [TBL] [Abstract][Full Text] [Related]
19. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Baum P; Kosacka J; Estrela-Lopis I; Woidt K; Serke H; Paeschke S; Stockinger M; Klöting N; Blüher M; Dorn M; Classen J; Thiery J; Bechmann I; Toyka KV; Nowicki M Metabolism; 2016 Apr; 65(4):391-405. PubMed ID: 26975531 [TBL] [Abstract][Full Text] [Related]
20. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients. Uluc K; Isak B; Borucu D; Temucin CM; Cetinkaya Y; Koytak PK; Tanridag T; Us O Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]